Difference in the color stability of direct and indirect resin composites

Indirect resin composites are generally regarded to have better color stability than direct resin composites since they possess higher conversion degree. OBJECTIVE: The present study aimed at comparing the changes in color (ΔE) and color coordinates (ΔL, Δa and Δb) of one direct (Estelite Sigma: 16 shades) and 2 indirect resin composites (BelleGlass NG: 16 shades; Sinfony: 26 shades) after thermocycling. MATERIAL AND METHODS: Resins were packed into a mold and light cured; post-curing was performed on indirect resins. Changes in color and color coordinates of 1-mm-thick specimens were determined after 5,000 cycles of thermocycling on a spectrophotometer. RESULTS: ΔE values were in the range of 0.3 to 1.2 units for direct resins, and 0.3 to 1.5 units for indirect resins, which were clinically acceptable (Δ

Bond strength of experimental cyanoacrylate-modified dental glass ionomer cements

Abstract Glass ionomer cement (GIC) has been successfully used in dental field for more than 40 years. Despite numerous advantages of GIC, low bond strength and slow setting rate limited conventional GICs for use only at low stress-bearing areas. To improve bond strength to tooth, two kinds of cyanoacrylates such as ethyl 2-cyanoacrylate (EC) and allyl 2-cyanoacrylate (AC) were added in a commercial GIC. Changes in setting time of cyanoacrylate-modified GICs (CMGICs) according to the concentration of cyanoacrylates and/or p-toluene sulfonic acid (TSA) was investigated using a rheometer. Shear bond strength to human dentin was measured. Biocompatibility was determined by the viability of fibroblasts. Optimal concentrations for EC and TSA were 5-10% of the GIC powder and 30% of the GIC liquid, respectively. EC-based CMGIC showed twofold increase of initial bond strength compared with conventional GIC. Also, AC-based CMGIC showed three times higher bond strength and similar biocompatibility compared with the GIC. Therefore, CMGIC materials can be widely applied in dental adhesive restoration field because they showed improved bond strength and proper setting time

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate

Background The objective of this report is to share the clinicopathological features of chemotherapy-induced toxic leukoencephalopathy, which is a rare and under-recognized disease, clinically characterized by rapidly progressive cognitive loss that often leads to sudden death. Case presentation A 64-year-old woman and a 63-year-old man, who had both suffered from a rapid deterioration of consciousness, were autopsied under the clinical impressions of either the central nervous system graft versus host disease (CNS-GVHD), infectious encephalitis, or autoimmune encephalitis. Both patients had been treated with multiple chemotherapy regimens, including adriamycin, cytarabine arabinoside, daunorubicin, fludarabine, azacitidine, and allogeneic peripheral blood stem cell transplantation to treat hematological malignancies (acute myelogenous leukemia and myelodysplastic syndrome). Neuropathological findings at autopsy revealed rarefaction and vacuolar changes of the white matter with axonal spheroids, reactive gliosis, and foamy macrophage infiltration, predominantly in the visual pathways of the occipital and temporal lobes. Damaged axons exhibited immunoreactivity to beta-amyloid, consistent with axonopathy. However, there was no lymphocyte infiltration that suggested CNS-GVHD or any type of encephalitis. Conclusion The neuropathology found in the presented cases had the characteristic features of toxic leukoencephalopathy (chemobrain). Our cases showed that toxic leukoencephalopathy can also be caused by chemotherapy drugs other than methotrexate.This research was supported by a fund (2021-ER1001-01) by the Research of Korea Disease Control and Prevention Agency. The role of the funder is financial support for the operation of the brain bank of Seoul National University Hospital and the operation of the brain donation program for the research

Effect of chitinase- 3- like protein 1 on glucose metabolism: In vitro skeletal muscle and human genetic association study

We investigated the effect of chitinase- 3- like protein 1 (CHI3L1) on glucose metabolism and its underlying mechanisms in skeletal muscle cells, and evaluated whether the observed effects are relevant in humans. CHI3L1 was associated with increased glucose uptake in skeletal muscles in an AMP- activated protein kinase (AMPK)- dependent manner, and with increased intracellular calcium levels via PAR2. The improvement in glucose metabolism observed in an intraperitoneal glucose tolerance test on male C57BL/6J mice supported this association. Inhibition of the CaMKK was associated with suppression of CHI3L1- mediated glucose uptake. Additionally, CHI3L1 was found to influence glucose uptake through the PI3K/AKT pathway. Results suggested that CHI3L1 stimulated the phosphorylation of AS160 and p38 MAPK downstream of AMPK and AKT, and the resultant GLUT4 translocation. In primary myoblast cells, stimulation of AMPK and AKT was observed in response to CHI3L1, underscoring the biological relevance of CHI3L1. CHI3L1 levels were elevated in cells under conditions that mimic exercise in vitro and in exercised mice in vivo, indicating that CHI3L1 is secreted during muscle contraction. Finally, similar associations between CHI3L1 and metabolic parameters were observed in humans alongside genotype associations between CHI3L1 and diabetes at the population level. CHI3L1 may be a potential therapeutic target for the treatment of diabetes.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/162777/2/fsb220907.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/162777/1/fsb220907_am.pd

Surgical Management of Left Ventricular Outflow Tract Obstruction after Biventricular Repair of Double Outlet Right Ventricle

Regardless of the preoperative morphology and the type of operation, left ventricular outflow tract obstruction (LVOTO) after biventricular repair of double outlet right ventricle (DORV) may develop. This report presents our 10-yr experience with surgical management of LVOTO after biventricular repair of DORV. Between 1996 and 2006, 15 patients underwent reoperation for subaortic stenosis after biventricular repair of DORV. The mean age at biventricular repair was 23.3±18.3 months (1.1-64.2). Biventricular repairs included tunnel constructions from the left ventricle to the aorta in 14 cases and an arterial switch operation in one. The mean left ventricle-to-aorta peak pressure gradient was 54.0±37.7 mmHg (15-140) after a mean follow-up of 9.5±6.3 yr. We performed extended septoplasty in nine patients and fibromuscular resection in six. There were no early or late mortality. There was one heart block and one aortic valve injury after an extended septoplasty, and two and one after a fibromuscular resection. No patient required reoperation for recurrent subaortic stenosis. The mean pressure gradient was 11.2±11.4 mmHg (0-34) after a mean follow-up of 5.6±2.7 yr. Extended septoplasty is a safe and effective method for the treatment of subaortic stenosis, especially in cases with a long-tunnel shaped LVOTO